EMBO Molecular Medicine (Jan 2024)

Gasdermin D in macrophages drives orchitis by regulating inflammation and antigen presentation processes

  • Chunmei Ma,
  • Jiajia Huang,
  • Yuying Jiang,
  • Lu Liu,
  • Na Wang,
  • Shaoqiong Huang,
  • Honghui Li,
  • Xiangyu Zhang,
  • Shuang Wen,
  • Bingwei Wang,
  • Shuo Yang

DOI
https://doi.org/10.1038/s44321-023-00016-8
Journal volume & issue
Vol. 16, no. 2
pp. 361 – 385

Abstract

Read online

Abstract Inflammation in the testes induced by infection and autoimmunity contributes significantly to male infertility, a public health issue. Current therapies using antibiotics and broad-spectrum anti-inflammatory drugs are ineffective against non-bacterial orchitis and induce side effects. This highlights the need to explore the pathogenesis of orchitis and develop alternative therapeutic strategies. In this study, we demonstrated that Gasdermin D (GSDMD) was activated in the testes during uropathogenic Escherichia coli (UPEC)-induced acute orchitis, and that GSDMD in macrophages induced inflammation and affected spermatogenesis during acute and chronic orchitis. In testicular macrophages, GSDMD promoted inflammation and antigen presentation, thereby enhancing the T-cell response after orchitis. Furthermore, the pharmacological inhibition of GSDMD alleviated the symptoms of UPEC-induced acute orchitis. Collectively, these findings provide the first demonstration of GSDMD’s role in driving orchitis and suggest that GSDMD may be a potential therapeutic target for treating orchitis.

Keywords